Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-06

Clinical Trial Update: A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol [Phase 2]

View source ↗

Summary

A Phase 2 mechanistic study investigating MAR001 in adults with elevated triglycerides and remnant cholesterol is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MAR001

Snippet

Sponsor: Marea Therapeutics | Conditions: Hypertriglyceridemia | Phase 2 | Status: RECRUITING